Northern Trust Corp Gritstone Bio, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Gritstone Bio, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 210,891 shares of GRTS stock, worth $6,326. This represents 0.0% of its overall portfolio holdings.

Number of Shares

210,891

Previous 730,879 71.15%

Holding current value

$6,326

Previous $453,000 73.07%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$0.45 - $0.71 $233,994 - $369,191	-519,988 Reduced 71.15%	210,891 $122,000
Q2 2024 Aug 14, 2024	SELL	$0.62 - $2.35 $14,622 - $55,422	-23,584 Reduced 3.13%	730,879 $453,000
Q1 2024 May 14, 2024	BUY	$1.96 - $2.9 $44,180 - $65,368	22,541 Added 3.08%	754,463 $1.94 Million
Q4 2023 Feb 13, 2024	BUY	$1.28 - $2.85 $11,261 - $25,074	8,798 Added 1.22%	731,922 $1.49 Million
Q3 2023 Nov 13, 2023	BUY	$1.19 - $2.26 $15,023 - $28,532	12,625 Added 1.78%	723,124 $1.24 Million
Q2 2023 Aug 11, 2023	BUY	$1.66 - $3.03 $926,178 - $1.69 Million	557,939 Added 365.72%	710,499 $1.39 Million
Q1 2023 May 15, 2023	BUY	$2.13 - $3.74 $8,285 - $14,548	3,890 Added 2.62%	152,560 $424,000
Q4 2022 Feb 13, 2023	BUY	$2.17 - $3.92 $55,009 - $99,372	25,350 Added 20.56%	148,670 $512,000
Q3 2022 Nov 14, 2022	BUY	$2.46 - $4.75 $19,778 - $38,190	8,040 Added 6.97%	123,320 $317,000
Q2 2022 Aug 12, 2022	SELL	$1.77 - $4.34 $497,488 - $1.22 Million	-281,067 Reduced 70.91%	115,280 $279,000
Q1 2022 May 13, 2022	SELL	$4.03 - $12.19 $50,612 - $153,094	-12,559 Reduced 3.07%	396,347 $1.63 Million
Q4 2021 Feb 08, 2022	BUY	$8.76 - $13.71 $346,046 - $541,586	39,503 Added 10.69%	408,906 $5.26 Million
Q3 2021 Nov 15, 2021	SELL	$6.41 - $13.54 $865,555 - $1.83 Million	-135,032 Reduced 26.77%	369,403 $3.99 Million
Q2 2021 Aug 13, 2021	BUY	$8.13 - $10.2 $1.8 Million - $2.26 Million	221,789 Added 78.47%	504,435 $4.61 Million
Q1 2021 May 12, 2021	SELL	$4.07 - $27.11 $66,369 - $442,082	-16,307 Reduced 5.45%	282,646 $2.67 Million
Q4 2020 Feb 11, 2021	SELL	$2.57 - $4.22 $47,185 - $77,479	-18,360 Reduced 5.79%	298,953 $1.18 Million
Q3 2020 Nov 16, 2020	SELL	$2.63 - $8.09 $55,729 - $171,427	-21,190 Reduced 6.26%	317,313 $841,000
Q2 2020 Aug 14, 2020	BUY	$5.69 - $8.17 $276,818 - $397,470	48,650 Added 16.78%	338,503 $2.25 Million
Q1 2020 May 14, 2020	BUY	$5.47 - $11.3 $56,133 - $115,960	10,262 Added 3.67%	289,853 $1.69 Million
Q4 2019 Feb 14, 2020	BUY	$7.07 - $11.61 $66,648 - $109,447	9,427 Added 3.49%	279,591 $2.51 Million
Q3 2019 Nov 13, 2019	BUY	$8.45 - $12.28 $1.31 Million - $1.9 Million	154,769 Added 134.12%	270,164 $2.33 Million
Q2 2019 Aug 13, 2019	BUY	$9.2 - $15.7 $341,494 - $582,768	37,119 Added 47.42%	115,395 $1.29 Million
Q1 2019 May 13, 2019	BUY	$9.97 - $18.96 $1,684 - $3,204	169 Added 0.22%	78,276 $1.04 Million
Q4 2018 Feb 12, 2019	BUY	$11.61 - $31.1 $906,822 - $2.43 Million	78,107 New	78,107 $1.21 Million

Others Institutions Holding GRTS

# of Institutions

Shares Held

35.4M

Call Options Held

395K

Put Options Held

132K

View Full List

About Gritstone bio, Inc.

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $2.19M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

More about GRTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Gritstone Bio, Inc. Transaction History